Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

The purpose of this study is to find out if the combination of docetaxel and capecitabine can shrink the size of breast tumors and preserve the breast.

Key facts

Study ID

NCT00209092

Run by

Emory University

People needed

51

Starts

2006-08-01

Expected to finish

2012-10-01

Last updated by the study team

2015-03-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Histologically or cytologically confirmed breast carcinoma.
• Early stage breast cancer (stage 1, 2, 3).
• No evidence of disease outside the breast or chest wall, except ipsilateral axillary lymph nodes.
• 18 years of age or older.
• Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

You may not qualify if…

• Prior chemotherapy, hormonal therapy, biologic therapy or radiation therapy for breast cancer.
• Major surgery within 28 days of study entry.
• Evidence of central nervous system (CNS) metastases.
• Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Where it is running

• Grady Memorial Hospital — Atlanta, Georgia, United States
• Emory Crawford Long Hospital — Atlanta, Georgia, United States
• Emory University Winship Cancer Institute — Atlanta, Georgia, United States
• Augusta Oncology Associates, PC 1348 Walton Way, Ste. 4300 — Augusta, Georgia, United States
• Augusta Oncology Associates, PC 3696 Wheeler Road — Augusta, Georgia, United States
• WellStar Health System-Georgia Cancer Specialists — Austell, Georgia, United States
• WellStar Health System-Northwest Georgia Oncology Center, PC — Austell, Georgia, United States
• WellStar Health System-Northwest Georgia Oncology Center, PC — Carrollton, Georgia, United States
• John B. Amos Cancer Center — Columbus, Georgia, United States
• Suburban Hematology-Oncology Associates, PC — Duluth, Georgia, United States
• South Atlanta Hematology-Oncology Group — East Point, Georgia, United States
• Suburban Hematology-Oncology Associates, PC — Lawrenceville, Georgia, United States
• Central Georgia Cancer Care, PC — Macon, Georgia, United States
• WellStar Health System-Georgia Cancer Specialists — Marietta, Georgia, United States
• WellStar Health System-Northwest Georgia Oncology Center, PC — Marietta, Georgia, United States
• South Atlanta Hematology-Oncology Group — Riverdale, Georgia, United States
• Suburban Hematology-Oncology Associates, PC — Snellville, Georgia, United States
• South Atlanta Hematology-Oncology Group — Stockbridge, Georgia, United States
• Central Georgia Cancer Care, PC — Warner Robins, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.